14 February 2012
The past three years have been a tumultuous time for the financials sector, which has seen a phase of deleveraging, rights issues and balance sheet repair which continues to this day.
06 February 2012
Newton manager predicts risk on trades will perform best in short term despite gloomy economic outlook.
13 January 2012
As income-producing stocks struggle to make total returns, Steven Andrew uses his fund’s ability to invest in bonds to outperform his peers.
09 January 2012
Dalton Strategic Partners fund manager Jenifer Rush adopts adventurous investment style to find ideas within the commodities sector.
12 December 2011
Flagship UK Opportunities fund invests in unloved names with encouraging growth prospects.
05 December 2011
Manager plays yield curve and looks for ‘dull’ core holdings in long-standing fund.
25 November 2011
The fund has broader remit than similar ethical products, including oil and gas exposure
18 November 2011
Malta-domiciled fund returned 81.42% over three years by tapping into burgeoning luxury brand market, with focus on EMs.
11 November 2011
SWIP’s James Clunie makes impressive turnaround on UK Flexible Strategy after the fund was hard hit during the 2008 crisis.
07 November 2011
Neptune US Income fund manager targets yield of 3.5%-4% per annum.
31 October 2011
Just over a year ago, Schroders added a second fund to its Income Maximiser range, aiming to provide investors with an annual yield of 7%, in the form of an Asian fund run by Richard Sennitt and Dr Thomas See.
24 October 2011
Focus on the ‘structural change in the way people work, entertain and communicate’ helps fund deliver 49% over three years.
17 October 2011
Low-profile F&C manager says attracting investors to mid-caps tough in current climate.
10 October 2011
IM Matterley Undervalued Assets fund delivers more than 30% to investors over three years as managers seek businesses trading below ‘build price’
19 August 2011
UK Mid Cap manager prevails through tough headwinds, steering fund to top of charts.
The next financial crisis will be sparked by the rise of giant daily dealing bond funds and ETFs, GLG’s top performing fixed income manager Jon Mawby has warned.
Matt Kamm, managing director of Artisan Partners, explains why, following their upswing, biotech stocks are still early in a pharmaceutical renaissance which should capture investor attention.
With monetary policy weakening the yen and a consumption tax rise at home, Japan's multinationals are the key to solving the country's problems - and the best bet for investors, says Neptune's Chris Taylor.
The Big Debate
The Big Debate is an online audio and video conferencing club with an audience comprising the UK's leading discretionary asset managers, top IFAs, and other investment professionals.
IW Fund Centre
Register here to get full access to all Investment Week's news and comment articles from our archive.
Updating your subscription status